Delaware Court Sides With Zantac Makers in Cancer Claims.

The article discusses a ruling by the Delaware Supreme Court that dismissed expert testimony linking the heartburn drug Zantac to cancer, marking a significant victory for its manufacturers, including GSK Plc, Pfizer Inc., and Boehringer Ingelheim Pharmaceuticals. The court found that the lower court judge, Vivian Medinilla, improperly allowed the testimony to proceed and should have acted as a gatekeeper to assess its reliability. The ruling sends the cases back to Medinilla for reevaluation, potentially allowing them to proceed to trial. Plaintiffs allege that Zantac, which contains the active ingredient ranitidine, can cause various cancers, a claim that has gained national attention following the FDA's 2020 request to remove ranitidine products from the market. [Extracted from the article]